UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 340.1	$ 488.3
Accounts receivable, net	475.4	492.0
Inventories	1,060.5	968.3
Other current assets	264.4	215.6
Total current assets	2,140.4	2,164.2
Property, plant and equipment, net	586.1	599.7
Goodwill	751.9	582.6
Intangible assets, net	449.2	330.5
Operating lease assets	105.1	91.7
Deferred tax assets	280.1	297.2
Other long-term assets	193.6	184.0
Total assets	4,506.4	4,249.9
Current liabilities:
Current portion of long-term debt	21.2	121.2
Accounts payable	199.1	202.7
Deferred revenue and customer advances	485.2	400.0
Other current liabilities	477.0	478.2
Total current liabilities	1,182.5	1,202.1
Long-term debt	1,357.3	1,160.3
Long-term deferred revenue and customer advances	105.6	91.5
Deferred tax liabilities	81.8	67.7
Operating lease liabilities	85.7	74.8
Accrued pension	76.0	76.6
Other long-term liabilities	166.7	163.6
Total liabilities	3,055.6	2,836.6
Commitments and contingencies (Note 16)
Redeemable noncontrolling interests	17.9	18.7
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 176,113,521 and 175,943,705 shares issued and 145,334,642 and 145,164,826 shares outstanding at March 31, 2024 and December 31, 2023, respectively.	1.7	1.7
Treasury stock, at cost, 30,778,879 shares at March 31, 2024, and December 31, 2023, respectively	(1,237.2)	(1,237.2)
Additional paid-in capital	291.1	282.9
Retained earnings	2,367.4	2,323.8
Accumulated other comprehensive (loss) income, net of tax	(7.7)	6.0
Total shareholders' equity attributable to Bruker Corporation	1,415.3	1,377.2
Noncontrolling interests in consolidated subsidiaries	17.6	17.4
Total shareholders' equity	1,432.9	1,394.6
Total liabilities, redeemable noncontrolling interests and shareholders' equity	$ 4,506.4	$ 4,249.9